(PharmaNewsWire.Com, September 13, 2024 ) Haemodialysis is a healthcare treatment for kidney failure patients that removes waste and fluids from the blood using a dialyzer machine. This process involves channelling blood through a pipe, cleaning it, and pumping it back to the body. Haemodialysis is typically performed three to four times weekly, helping regulate electrolytes, water content, and waste products in those with compromised kidney function. The market for haemodialysis has grown due to the increasing incidence of end-stage renal disease (ESRD), technological advancements, and improved consciousness. It includes dialysis equipment, blood lines, concentrates, accessories, and services offered by dialysis centers and home care markets.
The increasing prevalence of chronic kidney disease (CKD) across the globe is expected to drive the hemodialysis and peritoneal dialysis market. CKD may affect up to 10% of the population worldwide as CKD is on the rise due to factors such as an aging population, increasing prevalence of diabetes and hypertension, and the progression of CKD to end-stage renal disease, which is often seen. Chronic kidney disease (CKD) is a blood disorder that is more common among people over the age of 65. According to the Centers for Disease Control and Prevention (CDC), an estimated 35.5 million people in the United States will be affected by chronic kidney disease by 2023. The hemodialysis market is experiencing unique growth opportunities due to technological advancements in hemodialysis machines and related equipment. New technologies like portable dialysis machines, advanced membrane technologies, and AI-based data analysis are making treatments more effective and convenient for patients. Companies must invest in research and development to improve the dialysis process, make it easy to use, and reduce costs. Home hemodialysis is now a reality, creating new markets and patient groups with high growth potential.
Haemodialysis Market Regional Insights North America is expected to dominate the Haemodialysis Market in the future due to advancements in healthcare, high chronic kidney disease rates, and a growing diabetic and hypertension patient population. Major players, significant capital expenditure on R&D, and technological advancements in dialysis treatments further support this dominance. According to the National Institute of Diabetes and Digestive and Kidney Diseases, more than one in seven adults in the United States has chronic kidney disease. In addition, the increasing cost-effectiveness and favorable government programs are expected to favor the US dialysis market, thereby increasing the local industry. For example, the Centers for Medicare and Medicaid Services (CMS) pays for blood transfusions through a payment system (PPS), which allows blood transfusion providers to be paid a fixed amount.
The conventional hemodialysis segment is expected to dominate the market during the forecast period. Three primary modalities are conventional hemodialysis, daily hemodialysis, and nocturnal hemodialysis. Traditional hemodialysis involves three treatments per week, each lasting four hours. Daily hemodialysis offers convenience and efficiency, with patients treated five to six times a week for shorter periods. nocturnal hemodialysis offers long-slow dialysis benefits. The market is shifting due to the increasing need for personalized dialysis services. With advancements in technology and healthcare facilities prioritizing patients, the hemodialysis market has the potential to expand and improve on existing treatments.
By Dialysis Site: In-center dialysis Home dialysis By Product: Consumables Equipment Drugs
Haemodialysis Key Competitors include: Cargill, Incorporated (US) Nipro Corporation (Japan) DaVita Inc. (United States) B. Braun Melsungen AG (Germany) TORAY INDUSTRIES, INC. (Japan) Baxter International Inc. (US) Rockwell Medical Technologies Inc. (US) Nikkiso Co., Ltd (Japan) Diaverum Holding AB (Sweden) Asahi Kasei Corporation (Japan) and Others and other major players
Key questions answered in the Haemodialysis Market report are: 1. Which market segment dominated the global Haemodialysis market in 2023? 2. What are the current global trends in the Haemodialysis market? 3. What future industry applications and trends are emerging in the Haemodialysis market? 4. What growth strategies are companies adopting to expand their presence in the Haemodialysis market? 5. Who are the leading companies in the Haemodialysis market, and what are their product portfolios? 6. What are the primary challenges the Haemodialysis market may face in the future? 7. Which region had the largest share of the Haemodialysis market in 2023? 8. How is the regulatory environment influencing the Haemodialysis market? Key Offerings: Market Size, Share, Size & Forecast by Different Segments | 2024−2032 Haemodialysis Market Dynamics Growth Drivers, Restraints, Opportunities, and Key Trends by Region Market Trend Analysis Pestle Analysis Porters Five Forces Analysis Industry Value Chain Analysis Ecosystem Regulatory Landscape Price Trend Analysis Patent Analysis Technology Evolution Investment Pockets China Manufacturing as a Service Market Segmentation Competitive Landscape Profiles of selected key players from a strategic perspective Competitive landscape Competitive Benchmarking, US Dump trucks manufacturer Market Share by Manufacturer (2023), Industry BCG Matrix, Heat Map Analysis, Mergers & Acquisitions Analyst Viewpoint and Conclusion
Introspective Market Research, a prominent Healthcare research firm has released the following reports:
Global Lancing Devices & Lancets Market: Lancing Devices & Lancets Market Size Was Valued at USD 2.45 Billion in 2023 and is Projected to Reach USD 5.68 Billion by 2032, Growing at a CAGR of 9.8 % From 2024-2032.
Global Sleep Apnea Devices Market: The global Sleep Apnea Devices Market was valued at USD 5.9 billion in 2023 and is likely to reach USD 10.43 billion by 2032, increasing at a CAGR of 6.53% from 2024 to 2032.
About us:
Introspective Market Research Private Limited (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.
Get in Touch with Us:
Canada Office Introspective Market Research Private Limited,138 Downes Street Unit 6203, M5E 0E4, Toronto, Canada. APAC Office Introspective Market Research Private Limited, Office No. 403, Saudamini Commercial Complex, Kothrud, Pune, India 411038 Ph no: +1 773 382 1049 Email: sales@introspectivemarketresearch.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
